This morning I have done the last five trades so that the JIC Funds Portfolio is now as I want it ahead of the new quarter starting tomorrow.
Remember, I am taking a five year plus view with it and expect to make minimal changes along the way. It is unashamedly growth-oriented, which might mean over shorter time periods that when there is a market correction it gets hit hard. On the other hand, hopefully, the near 10% exposure to gold and to â€śQualityâ€ť companies as found in the likes of Fundsmith and Chelverton UK Growth, might mean my fears are overdone. I also expect the high exposure to healthcare, through Worldwide Healthcare Trust, and stocks held in some of the other funds, to provide not only good long-term growth but also an element of defensiveness.
It is a real portfolio; not my SIPP, (that is the JIC Portfolio) but the SIPP of someone close to me!
I will in the next few weeks write a â€śtop-downâ€ť review of the â€śJIC Funds Portfolioâ€ť structure and then review each individual fund in more detail.
After that, I will write a quarterly review and, starting in July 2021, a more comprehensive annual review and analysis of whether changes need to be made.
I have sold the two remaining individual stock positions; Duke Royalty and SDI Group. For the avoidance of doubt, I still like these stocks and they remain in the JIC Portfolio. Today, might not be the best time to sell but I was keen for the JIC Funds Portfolio to be in shape by this evening. I look forward to SDIâ€™s results on 21stÂ July.
With the proceeds, I have added long term favourite, Baillie Gifford Shin Nippon (BGS), Blackrock Greater Europe IT (BRGE) and JP Morgan Emerging Markets (JMG).
I have also added the FTSE All-World (GBP) Total Return Index to the Portfolio for comparison over various time periods.